MedElevator Войти в исследования
← Поиск публикаций

DOI 10.4269/ajtmh.25-0204

Медицинская библиотека · The American journal of tropical medicine and hygiene · 2025

Very Low Prevalence of Validated kelch13 Mutations and Absence of Histidine-Rich Protein 2/3 Double Gene Deletions in South African Malaria-Eliminating Districts (2022-2024).

Raman Jaishree, Mabona Maxwell, Nyawo Qedusizi, Mangena Brighton, Kok Gerdalize, Mathaba Lihle, Malatje Gillian, Lauterbach Sonja B, Makhanthisa Takalani I, Gwarinda Hazel, Letinić Blaženka D, Ndadza Arinao, Raswiswi Eric, Shandukani Mbavhalelo, Baloyi Ednah, Fekema Ziyanda, Ismail Arshad, Featherston Jonathan, Greenhouse Bryan, Smith Jennifer L, Aranda-Diaz Andres

СтатьяПеревод в очереди

Аннотация

South Africa is one of 25 countries identified by the WHO as having the potential to eliminate malaria in the near future. In response to the emerging threat of antimalarial resistance, South Africa has enhanced its surveillance programs to enable the mapping of the prevalence of resistance markers at the facility level. A total of 4,471 samples, collected between January 2022 and August 2024 from healthcare facilities and during active surveillance in malaria-eliminating districts in KwaZulu-Natal and Mpumalanga Provinces, were assessed for drug (mutations in the kelch13, chloroquine resistance transporter [crt], multidrug resistance 1 [mdr1], dihydrofolate reductase [dhfr], and dihydropterate synthase [dhps] genes) and diagnostic (histidine-rich protein 2/3 [hrp2/3] gene deletions) resistance markers using polymerase chain reaction testing and sequencing (Sanger or targeted amplicon) protocols. Validated markers of artemisinin partial resistance were rare, with the P574L mutation detected as a minor allele in two samples and the P553L mutation present in one sample. Of the 60 additional nonsynonymous mutations detected, the A578S (30/999) and the I494V (13/951) mutations were most prevalent. Almost all parasites assessed carried the crtK76 (99.8%) and mdr1N86 (99.0%) alleles, suggesting susceptibility to chloroquine. The dhfr triple (99.9%) and dhps double (98.2%) mutations associated with pyrimethamine and sulfadoxine resistance, respectively, were close to fixation. No single or double hrp2/3 gene deletions were detected. These findings suggest that the recommended treatments and diagnostics in South Africa are effective. However, the strong selection for antimalarial drug resistance markers across southern Africa, combined with high regional interconnectedness, emphasizes the need for sustained malaria molecular surveillance to support South Africa and the southern Africa region in achieving their elimination goals.

Для цитирования: Raman Jaishree, Mabona Maxwell, Nyawo Qedusizi, Mangena Brighton, Kok Gerdalize, Mathaba Lihle, Malatje Gillian, Lauterbach Sonja B, Makhanthisa Takalani I, Gwarinda Hazel, Letinić Blaženka D, Ndadza Arinao, Raswiswi Eric, Shandukani Mbavhalelo, Baloyi Ednah, Fekema Ziyanda, Ismail Arshad, Featherston Jonathan, Greenhouse Bryan, Smith Jennifer L, Aranda-Diaz Andres. Very Low Prevalence of Validated kelch13 Mutations and Absence of Histidine-Rich Protein 2/3 Double Gene Deletions in South African Malaria-Eliminating Districts (2022-2024).. The American journal of tropical medicine and hygiene. 2025. DOI: 10.4269/ajtmh.25-0204.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.